However, as the activation of Chk1 and ATR promotes cell cycle arrest and DNA repair [15], inhibition of these kinases by small compounds was conceived as an opportunity to selectively sensitize tumour cells that heavily rely on this pathway for cell survival [16,17]. This evidence concerns the gene CHEK1 and neoplasm.